Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SNACS: Single Dose vs Double Dose Celestone for Preterm Delivery
NCT05114096Phase 4Recruiting
- Sponsor
- McMaster University
- Start
- Jul 2023
- Primary completion
- Dec 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of betamethasone in preterm birth and Complications of prematurity (2 arms), sponsored by McMaster University. Primary endpoint: Perinatal Mortality or Substantial Neonatal Morbidity at 1 month. Started Jul 2023; status: recruiting.
02
Drugs
betamethasone
03
Conditions
preterm birthComplications of prematurity
Beyond the preview
Go deeper on NCT05114096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05114096.